Small Molecule Tyrosine Kinase Inhibitors: Potential Role in Pediatric Malignant Solid Tumors

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 76-85

Bentham Science Publishers

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

By Delaunoit Thierry   Burch Patrick   Reid Joel   Camoriano John   Kobayash Tomowo   Braich Theodore   Kaur Judith   Rubin Joseph   Erlichman Charles  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 327-333

Springer Publishing Company

Access to resources Recommend Favorite

Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use

By Frampton Adam E   Gall Tamara MH   Giovannetti Elisa   Stebbing Justin   Castellano Leandro   Jiao Long R   Krell Jonathan  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 4, 2013-05 ,pp. : 325-329

Informa Healthcare

Access to resources Recommend Favorite

Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study

By Davies Angela   Ho Cheryl   Hesketh Paul   Beckett Laurel   Lara Primo   Lau Derick   Gandara David  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 351-355

Springer Publishing Company

Access to resources Recommend Favorite

Ixabepilone for the treatment of solid tumors: a review of clinical data

By Denduluri Neelima   Swain Sandra M  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 423-435

Informa Healthcare

Access to resources Recommend Favorite